Arcadia Biosciences Inc (NASDAQ:RKDA) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totalling 89,800 shares, a growth of 18.3% from the June 30th total of 75,900 shares. Based on an average daily trading volume, of 1,000,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.8% of the shares of the stock are sold short.
A number of brokerages recently weighed in on RKDA. HC Wainwright restated a “buy” rating on shares of Arcadia Biosciences in a report on Monday. ValuEngine upgraded shares of Arcadia Biosciences from a “sell” rating to a “hold” rating in a report on Thursday, August 1st. Finally, National Securities restated a “buy” rating and set a $15.00 target price on shares of Arcadia Biosciences in a report on Thursday, May 9th.
Arcadia Biosciences stock traded up $0.96 during midday trading on Wednesday, reaching $7.05. The stock had a trading volume of 10,441,700 shares, compared to its average volume of 1,202,870. The firm has a fifty day moving average of $3.10. Arcadia Biosciences has a twelve month low of $1.82 and a twelve month high of $10.40. The company has a debt-to-equity ratio of 2.80, a quick ratio of 6.19 and a current ratio of 6.26. The firm has a market cap of $28.26 million, a price-to-earnings ratio of -1.32 and a beta of -2.01.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.
See Also: Stochastic Momentum Index (SMI)
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.